Загрузка...
Facile accelerated specific therapeutic (FAST) platform develops antisense therapies to counter multidrug-resistant bacteria
Multidrug-resistant (MDR) bacteria pose a grave concern to global health, which is perpetuated by a lack of new treatments and countermeasure platforms to combat outbreaks or antibiotic resistance. To address this, we have developed a Facile Accelerated Specific Therapeutic (FAST) platform that can...
Сохранить в:
| Опубликовано в: : | Commun Biol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group UK
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7955031/ https://ncbi.nlm.nih.gov/pubmed/33712689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-021-01856-1 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|